Here's how you try to discredit someone's opinions: you

New Post Public Reply Private Reply Replies (0) Message Board
Drano
Here's how you try to discredit someone's opinions: you misstate what they are saying, focus the attention away from the point they made, and then ridicule the point you are pretending that they are making (which is NOT the point they made).

The spin-and-distort project is now focusing on how "there is no downside to uplisting." Well, NO downside is a blanket statement that can be challenged (see: abuse of options to assist in manipulating stock price) BUT -- I will go on the record as saying I believe that uplisting is a good thing for CTIX.

But that's not the issue.

The issue is, HOW is uplisting achieved, and what is the timing?

Why would someone continually urge uplisting by a reverse split. when the company is grossly undervalued and has a large number of significant, share-price-moving events coming up? Given the history of poor results from reverse splits and the extreme stigma attached to stocks that have to do reverse splits, why would anyone do that when a small amount of patience would make that unnecessary?

Why would someone be in such a hurry to uplist that they continually urge a disastrous course of action that the CEO has said he WILL NOT do?

It's all in the timing.

If a stock is going to have a lot of major scientific results by the end of the year, people who want to pump and then dump the stock need to do it BEFORE the news is out -- because if there is great news from a clinical trial, the stock could easily triple in a trading day, as DNDN did way back when.

And if the stock can no longer be attacked as supposedly having no credible results, and no partner, and no hope of revenues -- and then all of those things are proven to be untrue with one press release -- how can the scumbags fully profit? If it is known that a company has, for instance, a novel new class of antibiotics that will be worth billions, how can someone continually claim that the company is doomed, or that share price will drop 40% soon?

From their standpoint, they'd rather do an AVXL operation on CTIX -- run it up on reverse split/uplisting plan, then take it right back down into the cellar. And since with normal stocks it takes several months before options start trading, it needs to be done NOW if they are able to get their trading plan in place that includes options, before all the news of clinical trial results for all FOUR different clinical trials (plus the new ones) can be released.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ingersoll Rand Expands Air Treatment Portfolio with Acquisitions

Updated Category News Views 247

Ingersoll Rand Strengthens Its Market Position Through Acquisitions Ingersoll Rand Inc. continues to bolster its position in the air treatment sector with strategic acquisitions aimed at expanding its product offerings and enhancing customer solutions. The company has recently acquired G & D Chillers, Inc. and Advanced Gas Technologies Inc. for a total of approximately...

Continue Reading
Braemar Hotels & Resorts Transitions Annual Meeting to Virtual Event

Updated Category News Views 205

Braemar Hotels & Resorts Embraces a Virtual Format for Their Meeting DALLAS — Braemar Hotels & Resorts Inc. (NYSE: BHR) has made an important announcement regarding its upcoming 2025 Annual Meeting of Stockholders. The company has decided to shift the format from an in-person gathering to a virtual experience through a live online webcast. The Annual Meeting is...

Continue Reading
Key Stock Highlights: Broadcom, Oracle and Netflix Gains

Updated Category News Views 205

Retail Investors' Hot Picks This Week This past week saw retail investors buzzing about several noteworthy stocks, driven by remarkable earnings reports and ongoing retail enthusiasm, particularly around tech and automotive sectors. Broadcom Inc. (NASDAQ: AVGO) Broadcom Inc. captured significant attention following its fiscal fourth-quarter earnings release, reporting an...

Continue Reading
Blue Hat Faces Challenges with Stock at Record Low of $0.27

Updated Category News Views 83

Blue Hat Struggles with Stock Performance Blue Hat Interactive Entertainment Technology (BHAT) stock has reached a significant 52-week low, currently priced at just $0.27. This decline highlights a difficult period for the company, which has seen its stock value decrease by an alarming 87% over the past year. Investors are feeling the pressure as the firm faces market...

Continue Reading
Investigating Hillenbrand, Inc.'s Sale - What Shareholders Should Know

Updated Category News Views 418

Understanding the Investigation into Hillenbrand, Inc. Hillenbrand, Inc. (NYSE: HI) is currently under scrutiny regarding its recent sale to an affiliate of Lone Star Funds, valued at $32.00 per share in cash. The investigation led by Halper Sadeh LLC focuses on whether this deal is fair to Hillenbrand shareholders. As an investor rights law firm, Halper Sadeh is...

Continue Reading